| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-28 | FY 2024
FILED 2024-12-29 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.98B | $2.64B | $2.90B |
| YoY Revenue Growth % | +13.1% | -9.0% | — |
| Gross Profit | $246.6M | $220.7M | — |
| Gross Margin % | 8.3% | 8.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $92.8M | $86.8M | -$77.6M |
| Operating Margin % | 3.1% | 3.3% | -2.7% |
| Net Income (GAAP) | $22.4M | -$6.7M | -$186.2M |
| EBITDA (Normalized) | $161.9M | $166.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $78.1M | $158.2M | $167.5M |
| Capital Expenditures (CapEx) | $86.3M | $99.3M | — |
| Free Cash Flow (FCF) | -$8.2M | $58.9M | $167.5M |
| FCF Margin % | -0.3% | 2.2% | 5.8% |
| Return on Invested Capital (ROIC %) | 5.0% | 5.1% | — |
| Cash & Short-Term Equivalents | $126.6M | $49.0M | — |
| Total Debt (Short + Long Term) | $708.1M | $843.9M | — |
| Total Stockholders' Equity | $873.0M | $555.6M | — |